<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2020</year>
    <pub-dates>
     <date>2020-09-16</date>
    </pub-dates>
   </dates>
   <doi>10.1007/s11094-020-02184-0</doi>
   <abstract>A conjugate of glycyrrhizic acid (GA) with L-phenylalanine methyl ester was synthesized using N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. Chemical modification of GA via addition of L-phenylalanine methyl ester moieties in the carbohydrate part of the glycoside was shown to form a marginally toxic compound with high anti-inflammatory activity in carrageenan- and formalin-induced mouse inflammation models and with pronounced antiulcer activity in rats. This was a significant advantage of this compound over known anti-inflammatory drugs.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/1041</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1190</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
